We have some exciting news to share! The Motley Fool UK has now become an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. We’ll be introducing a new name and brand over the coming weeks — we're very excited to share it with you and embark on this new chapter together!

3 FTSE 100 shares that have tanked…but should bounce back!

Over the last six months, these FTSE 100 stocks have fallen between 21% and 32%. Edward Sheldon expects them to rebound at some stage in the future.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Young Asian woman with head in hands at her desk

Image source: Getty Images

Investing in high-quality FTSE 100 companies when their share prices are down is a strategy that can pay off. Usually, high-quality stocks recover after share price weakness, delivering big gains for investors who bought in at low prices.

Here, I’m going to highlight three high-quality Footsie stocks that have tanked over the last six months. I believe all three shares have the potential to stage powerful rebounds at some stage in the not-too-distant future.

Weight-loss drug fears

First up is healthcare company Smith & Nephew (LSE: SN.).

Like a lot of medical device companies, it has tanked recently amid fears that GLP-1 weight-loss drugs such as Wegovy and Ozempic are going to reduce demand for healthcare procedures. Over the last six months, it has fallen about 21%.

Now, while there’s definitely some uncertainty around the impact of weight-loss drugs, I expect this stock to rebound at some stage.

At present, it’s trading on a forward-looking P/E ratio of just 11.6, which seems too low for a company that a) should be able to generate solid growth in the years ahead on the back of the world’s ageing population and b) has paid a dividend every year since 1937.

It’s worth noting that Smith & Nephew’s Relative Strength Index or ‘RSI’ (a measure of whether a stock is overbought or oversold) is currently below 30. This indicates that the stock is extremely oversold right now.

Of course, there’s no guarantee that the stock will rebound in the near term. Eventually though, investors should see the value on offer here.

China woes

Next, we have insurance company Prudential (LSE: PRU).

It’s down significantly this year on the back of concerns over economic conditions in China and other Asian markets (the insurer is focused predominantly on Asia and Africa today). Over the last six months, it has fallen about 22%.

While China is really struggling at the moment (and may continue to struggle for a while), I expect the world’s second-largest economy to recover at some stage. And when it does, Prudential’s earnings, and share price, should get a boost.

Looking ahead, the company’s long-term growth remains huge. Across Asia and Africa, large proportions of the population are in need of savings and insurance products.

And what’s encouraging is that many brokers have share price targets for Prudential that are above the 1,500p mark. This implies that they see share price gains of 50% or more here.

Luxury spending downturn

Finally, there’s luxury goods company Burberry (LSE: BRBY).

Like many other luxury goods stocks (LVMH, Richemont, etc.), it has tanked recently on the back of lower demand for luxury products (a lot of this is related to China as the country accounts for around 20% of global luxury goods spending). Over the last six months, it has fallen about 32%.

I expect a recovery at some point. This is a high-quality company with a strong brand, a growing top line, a robust balance sheet, and a high level of profitability. And right now, it looks cheap (the forward-looking P/E ratio is only about 15).

Of course, if economic conditions continue to deteriorate, the stock could come under more pressure.

Taking a longer-term view, however, I think the share price is likely to move higher.

Edward Sheldon has positions in Prudential Plc and Smith & Nephew Plc. The Motley Fool UK has recommended Burberry Group Plc, Prudential Plc, and Smith & Nephew Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Market Movers

Investing Articles

Here’s why the Diageo share price is up 12% in a month!

The Diageo share price has been moving in the right direction recently, including a 5.3% rise today. Can it keep…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Why is the Trainline share price falling when revenues are growing?

Today's results have sent the Trainline share price down sharply in early trading. But our writer thinks they offered reasons…

Read more »

British pound data
Investing Articles

FTSE 100 falls as HSBC shares drop 5% after earnings miss – investors weigh up rising risks

Andrew Mackie examines HSBC’s earnings miss and what it signals for FTSE 100 banks, credit risk, and the wider market…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

HSBC shares slump 6%! What’s happened, and is this a buying opportunity?

HSBC shares are leading the FTSE 100 lower after Q1 numbers were poorly received. The question is, should investors now…

Read more »

Hydrogen testing at DLR Cologne
Investing Articles

17% below their 52-week high, is now an opportunity to consider Rolls-Royce shares?

Rolls-Royce Holdings shares have fallen significantly since March. James Beard asks whether now could be a good time for latecomers…

Read more »

Investing Articles

As Endeavour Mining shares jump 7% on Q1 results, is this a way into the gold rush?

Endeavour Mining shares have more than doubled over the past 12 months as gold has soared. But how much risk…

Read more »

Investing Articles

As Standard Chartered shares jump on impressive Q1, is this a FTSE 100 banking bargain?

It's a record quarter for Standard Chartered, with FTSE 100 bank shares under Q1 scrutiny at a time of unusual…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Are Unilever shares the perfect ISA buy for troubled times after Q1 impresses?

Unilever shares have been wobbling as restructuring plans make profitability hard to get a handle on. But the cash is…

Read more »